BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP), an emerging pharmaceutical company developing prostone-based therapies for age-related and other diseases, today announced that Ryuji Ueno, M.D., Ph.D., Ph.D., Founder, Chairman and Chief Executive Officer, will open the NASDAQ stock market on Monday, October 22, 2007. Dr. Ueno will be joined by members of the Sucampo management team.
